Advanced
  Home Compare Reports

Comparison with Similar Reports

Patient Handling Equipment Market by Type (Patient Transfer Devices (Lifts, Slings, Sliding Sheets), Electrical Medical Beds, Mobility Devices (Powere...

Publisher:        MarketsandMarkets

# of Pages:        286

Rating: 

1 User License $4,950

Publication Date:  December, 2021

Price:       $4,950 / User License




1 INTRODUCTION 34
1.1 OBJECTIVES OF THE STUDY 34
1.2 MARKET DEFINITION 34
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 34
1.2.2 MARKETS COVERED 35
FIGURE 1 PATIENT HANDLING EQUIPMENT MARKET SEGMENTATION 35
1.2.3 YEARS CONSIDERED FOR THE STUDY 35
1.3 CURRENCY 36
1.4 LIMITATIONS 36
1.5 STAKEHOLDERS 36
1.6 SUMMARY OF CHANGES 37
2 RESEARCH METHODOLOGY 38
2.1 RESEARCH APPROACH 38
FIGURE 2 RESEARCH DESIGN 38
2.1.1 SECONDARY RESEARCH 39
2.1.1.1 Key data from secondary sources 39
2.1.2 PRIMARY DATA 40
FIGURE 3 PRIMARY SOURCES 40
2.1.2.1 Key data from primary sources 41
2.1.2.2 Insights from primary experts 41
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 42
2.2 MARKET SIZE ESTIMATION 42
FIGURE 5 MARKET SIZE ESTIMATION: DEMAND-SIDE MODELING 43
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 44
FIGURE 7 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE PATIENT HANDLING EQUIPMENT MARKET (2021–2026) 45
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 45
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 47
FIGURE 9 MARKET DATA TRIANGULATION METHODOLOGY 47
2.4 MARKET SHARE ANALYSIS 48
2.5 ASSUMPTIONS FOR THE STUDY 48
2.6 LIMITATIONS 48
2.6.1 METHODOLOGY-RELATED LIMITATIONS 48
2.7 RISK ASSESSMENT 49
TABLE 1 RISK ASSESSMENT: PATIENT HANDLING EQUIPMENT MARKET 49
 
3 EXECUTIVE SUMMARY 50
FIGURE 10 PATIENT HANDLING EQUIPMENT MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 50
FIGURE 11 PATIENT TRANSFER DEVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 51
FIGURE 12 MEDICAL BEDS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 51
FIGURE 13 MEDICAL BEDS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION) 52
FIGURE 14 MOBILITY DEVICES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 52
FIGURE 15 PATIENT HANDLING EQUIPMENT MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 53
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF THE PATIENT HANDLING EQUIPMENT MARKET 53
4 PREMIUM INSIGHTS 55
4.1 PATIENT HANDLING EQUIPMENT MARKET OVERVIEW 55
FIGURE 17 RISING GERIATRIC & OBESE POPULATION TO DRIVE MARKET GROWTH 55
4.2 ASIA PACIFIC: PATIENT HANDLING EQUIPMENT MARKET, BY TYPE AND COUNTRY (2020) 56
FIGURE 18 PATIENT TRANSFER DEVICES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC MARKET IN 2020 56
4.3 PATIENT HANDLING EQUIPMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 57
FIGURE 19 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 57
4.4 REGIONAL MIX: PATIENT HANDLING EQUIPMENT MARKET (2021−2026) 58
FIGURE 20 EUROPE DOMINATES THE PATIENT HANDLING EQUIPMENT MARKET 58
4.5 PATIENT HANDLING EQUIPMENT MARKET: DEVELOPING VS. DEVELOPED MARKETS 58
FIGURE 21 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD 58
5 MARKET OVERVIEW 59
5.1 INTRODUCTION 59
5.2 MARKET DYNAMICS 59
FIGURE 22 PATIENT HANDLING EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 59
TABLE 2 MARKET DYNAMICS: IMPACT ANALYSIS 60
5.2.1 DRIVERS 60
5.2.1.1 Rising geriatric and obese population 60
TABLE 3 GERIATRIC POPULATION, BY REGION, 2018 VS. 2020 60
5.2.1.2 High risk of injuries to caregivers during the manual handling of patients 61
5.2.1.3 Implementation of regulations ensuring the safety of healthcare personnel during the manual lifting process 61
5.2.1.4 Growing patient admissions in hospitals 62
5.2.2 RESTRAINTS 62
5.2.2.1 Lack of training provided to caregivers for the efficient operation of patient handling equipment 62
5.2.3 OPPORTUNITIES 63
5.2.3.1 Rising demand for home healthcare services 63
5.2.4 CHALLENGES 63
5.2.4.1 Persistent difficulties in handling bariatric patients 63
5.2.4.2 Improper physical environment 63
5.3 COVID-19 IMPACT ON THE MARKET 64
5.4 PATENT ANALYSIS 65
5.4.1 PATENT PUBLICATION TRENDS FOR PATIENT HANDLING EQUIPMENT 65
FIGURE 23 PATENT PUBLICATION TRENDS (JANUARY 2011–NOVEMBER 2021) 65
5.4.2 JURISDICTION AND TOP APPLICANT ANALYSIS 66
FIGURE 24 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR PATIENT HANDLING EQUIPMENT (JANUARY 2011 TO NOVEMBER 2021) 66
FIGURE 25 TOP APPLICANT COUNTRIES/REGIONS FOR PATIENT HANDLING EQUIPMENT (JANUARY 2011 TO NOVEMBER 2021) 67
5.5 REGULATORY ANALYSIS 67
5.5.1 NORTH AMERICA 67
5.5.1.1 US 67
TABLE 4 US: REGULATORY PROCESS FOR MEDICAL DEVICES 68
5.5.1.2 Canada 68
5.5.2 EUROPE 68
5.5.3 ASIA PACIFIC 68
5.5.3.1 Japan 68
TABLE 5 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY 69
5.5.3.2 China 69
TABLE 6 NMPA MEDICAL DEVICES CLASSIFICATION 69
5.5.3.3 India 70
5.6 PRICING ANALYSIS 70
TABLE 7 PRICE RANGE FOR PATIENT HANDLING EQUIPMENT 71
5.7 TECHNOLOGY ANALYSIS 71
5.8 ECOSYSTEM ANALYSIS 72
FIGURE 26 ECOSYSTEM ANALYSIS: PATIENT HANDLING EQUIPMENT MARKET 72
5.9 VALUE CHAIN ANALYSIS 72
FIGURE 27 VALUE CHAIN ANALYSIS: PATIENT HANDLING EQUIPMENT 73
5.10 PORTER’S FIVE FORCES ANALYSIS 73
TABLE 8 PORTER’S FIVE FORCES ANALYSIS 73
5.10.1 THREAT OF NEW ENTRANTS 74
5.10.2 THREAT OF SUBSTITUTES 74
5.10.3 BARGAINING POWER OF SUPPLIERS 74
5.10.4 BARGAINING POWER OF BUYERS 74
5.10.5 INTENSITY OF COMPETITIVE RIVALRY 75
5.11 TRADE ANALYSIS: KEY MARKETS FOR IMPORT/EXPORT 75
5.11.1 EXPORT SCENARIO OF INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, AND VETERINARY SCIENCES 75
FIGURE 28 EXPORTS OF INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, AND VETERINARY SCIENCES, BY COUNTRY, 2020 (USD BILLION) 75
5.11.2 IMPORT SCENARIO OF INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, AND VETERINARY SCIENCES 76
FIGURE 29 IMPORTS OF INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, AND VETERINARY SCIENCES, BY COUNTRY, 2020 (USD BILLION) 76
6 INDUSTRY INSIGHTS 77
6.1 INTRODUCTION 77
6.2 INDUSTRY TRENDS 77
6.2.1 GROWING FOCUS ON ORGANIC GROWTH STRATEGIES 77
TABLE 9 NUMBER OF PRODUCT LAUNCHES BY KEY PLAYERS,
JANUARY 2018–OCTOBER 2021 77
6.2.2 GROWING PREFERENCE FOR SMART BEDS 78
6.2.3 INTEGRATION OF IOT IN PATIENT HANDLING EQUIPMENT 78
7 PATIENT HANDLING EQUIPMENT MARKET, BY TYPE 80
7.1 INTRODUCTION 81
TABLE 10 PATIENT HANDLING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 81
7.2 PATIENT TRANSFER DEVICES 81
TABLE 11 PATIENT TRANSFER DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 81
TABLE 12 PATIENT TRANSFER DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 82
7.2.1 PATIENT LIFTS 82
TABLE 13 PATIENT LIFTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 82
TABLE 14 PATIENT LIFTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 83
7.2.1.1 Ceiling lifts 83
7.2.1.1.1 Ceiling lifts accounted for the largest share of the patient lifts market in 2020 83
TABLE 15 MAJOR COMPANIES OFFERING CEILING LIFTS 84
TABLE 16 CEILING LIFTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 84
7.2.1.2 Stair & wheelchair lifts 85
7.2.1.2.1 Increasing preference for home care is
driving market growth 85
TABLE 17 STAIR & WHEELCHAIR LIFTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 85
TABLE 18 MAJOR COMPANIES OFFERING STAIR & WHEELCHAIR LIFTS 86
7.2.1.3 Mobile lifts 86
7.2.1.3.1 Advantages of mobile lifts have driven end-user demand 86
TABLE 19 MOBILE LIFTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 87
TABLE 20 MAJOR COMPANIES OFFERING MOBILE LIFTS 87
7.2.1.4 Sit-to-stand lifts 87
7.2.1.4.1 Growth in the elderly population is expected to foster the adoption of sit-to-stand lifts 87
TABLE 21 SIT-TO-STAND LIFTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 88
TABLE 22 MAJOR COMPANIES OFFERING SIT-TO-STAND LIFTS 88
7.2.1.5 Bath & pool lifts 89
7.2.1.5.1 Growth in the aged and disabled population has driven the demand for bath & pool lifts 89
TABLE 23 BATH & POOL LIFTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 89
7.2.2 SLINGS 89
7.2.2.1 Government policies promoting the use of medical lifting slings have increased their adoption 89
TABLE 24 SLINGS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 90
7.2.3 AIR-ASSISTED LATERAL TRANSFER MATTRESSES 90
TABLE 25 AIR-ASSISTED LATERAL TRANSFER MATTRESSES MARKET, BY TYPE,
2019–2026 (USD MILLION) 90
TABLE 26 AIR-ASSISTED LATERAL TRANSFER MATTRESSES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 91
TABLE 27 MAJOR COMPANIES OFFERING AIR-ASSISTED LATERAL TRANSFER MATTRESSES 91
7.2.3.1 Reusable mattresses 92
7.2.3.1.1 Durability and long lifespan have driven the demand for reusable mattresses 92
TABLE 28 REUSABLE AIR-ASSISTED MATTRESSES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 92
7.2.3.2 Single-patient use mattresses 93
7.2.3.2.1 Disposable air-assisted mattresses save costs and logistics associated with laundering 93
TABLE 29 SINGLE-PATIENT USE AIR-ASSISTED MATTRESSES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 93
7.2.4 SLIDING SHEETS 94
7.2.4.1 Sliding sheets facilitate safer and easier movement of patients 94
TABLE 30 SLIDING SHEETS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 94
TABLE 31 MAJOR COMPANIES OFFERING SLIDING SHEETS 95
7.2.5 ACCESSORIES 95
TABLE 32 ACCESSORIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 95
7.3 MEDICAL BEDS 96
TABLE 33 MEDICAL BEDS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 96
7.3.1 MEDICAL BEDS, BY TYPE 97
TABLE 34 MEDICAL BEDS MARKET, BY TYPE, 2019–2026 (USD MILLION) 97
7.3.1.1 Electric beds 97
7.3.1.1.1 Electric beds are adjustable and reduce manual patient handling tasks 97
TABLE 35 ELECTRIC BEDS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 98
7.3.1.2 Manual beds 98
7.3.1.2.1 Manual beds are cost-effective and beneficial for small healthcare settings 98
TABLE 36 MANUAL BEDS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 99
7.3.1.3 Semi-electric beds 99
7.3.1.3.1 Semi-electric beds are lightweight, easy to use, and economical 99
TABLE 37 SEMI-ELECTRIC BEDS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 100
7.3.2 MEDICAL BEDS, BY APPLICATION 100
TABLE 38 MEDICAL BEDS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 100
TABLE 39 EXAMPLES OF MEDICAL BEDS 101
7.3.2.1 Acute care 101
7.3.2.1.1 Growing number of critically ill patients to drive the market for acute care beds 101
TABLE 40 MEDICAL BEDS MARKET FOR ACUTE CARE, BY COUNTRY,
2019–2026 (USD MILLION) 102
7.3.2.2 Long-term care 102
7.3.2.2.1 Demand for long-term care is increasing globally 102
TABLE 41 MEDICAL BEDS MARKET FOR LONG-TERM CARE, BY COUNTRY,
2019–2026 (USD MILLION) 103
7.3.2.3 Rehabilitation care 103
7.3.2.3.1 Adoption of rehabilitation services is increasing due to the increasing prevalence of chronic diseases 103
TABLE 42 MEDICAL BEDS MARKET FOR REHABILITATION CARE, BY COUNTRY,
2019–2026 (USD MILLION) 104
7.3.2.4 Bariatric care 104
7.3.2.4.1 Rising demand for specially designed beds for obese patients is a key market driver 104
TABLE 43 MEDICAL BEDS MARKET FOR BARIATRIC CARE, BY COUNTRY,
2019–2026 (USD MILLION) 105
7.3.2.5 Other applications 105
TABLE 44 MEDICAL BEDS MARKET FOR OTHER APPLICATIONS, BY COUNTRY,
2019–2026 (USD MILLION) 106
7.4 MOBILITY DEVICES 106
TABLE 45 MOBILITY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 106
TABLE 46 MOBILITY DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 107
7.4.1 WHEELCHAIRS & MOBILITY SCOOTERS 107
TABLE 47 WHEELCHAIRS & MOBILITY SCOOTERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 107
TABLE 48 WHEELCHAIRS & MOBILITY SCOOTERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 108
7.4.1.1 Powered wheelchairs 108
7.4.1.1.1 Advantages over other wheelchair types have contributed to the demand for powered wheelchairs 108
TABLE 49 POWERED WHEELCHAIRS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 109
7.4.1.2 Mobility scooters 109
7.4.1.2.1 Mobility scooters help users to travel across long distances 109
 
TABLE 50 MOBILITY SCOOTERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 110
7.4.1.3 Manual wheelchairs 110
7.4.1.3.1 Manual wheelchairs are affordable and cost less than powered wheelchairs 110
TABLE 51 MANUAL WHEELCHAIRS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 111
TABLE 52 EXAMPLES OF WHEELCHAIRS 111
7.4.2 AMBULATORY AIDS 111
7.4.2.1 Increasing incidence of lifestyle diseases to drive the demand for ambulatory aids 111
TABLE 53 AMBULATORY AIDS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 112
7.5 BATHROOM & TOILET ASSIST EQUIPMENT 112
7.5.1 BATHROOM & TOILET ASSIST EQUIPMENT PROVIDE EASY MOBILITY SOLUTIONS FOR PEOPLE AFFECTED BY NEUROMUSCULAR DISORDERS 112
TABLE 54 BATHROOM & TOILET ASSIST EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 113
7.6 STRETCHERS & TRANSPORT CHAIRS 113
7.6.1 TECHNOLOGICAL ADVANCEMENTS ARE DRIVING THE MARKET FOR STRETCHERS & TRANSPORT CHAIRS 113
TABLE 55 STRETCHERS & TRANSPORT CHAIRS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 114
8 PATIENT HANDLING EQUIPMENT MARKET, BY END USER 115
8.1 INTRODUCTION 116
TABLE 56 PATIENT HANDLING EQUIPMENT MARKET, BY END USER,
2019–2026 (USD MILLION) 116
8.2 HOSPITALS 116
8.2.1 HOSPITALS ARE THE LARGEST END USERS OF PATIENT HANDLING EQUIPMENT 116
TABLE 57 XPATIENT HANDLING EQUIPMENT MARKET FOR HOSPITALS, BY COUNTRY, 2019–2026 (USD MILLION) 117
8.3 HOME CARE SETTINGS 117
8.3.1 RISING DEMAND FOR HOME CARE TO SUPPORT MARKET GROWTH 117
TABLE 58 PATIENT HANDLING EQUIPMENT MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2019–2026 (USD MILLION) 118
8.4 OTHER END USERS 118
TABLE 59 PATIENT HANDLING EQUIPMENT MARKET FOR OTHER END USERS,
BY COUNTRY, 2019–2026 (USD MILLION) 119
9 PATIENT HANDLING EQUIPMENT MARKET, BY REGION 120
9.1 INTRODUCTION 121
FIGURE 30 PATIENT HANDLING EQUIPMENT: GEOGRAPHIC GROWTH OPPORTUNITIES 121
TABLE 60 PATIENT HANDLING EQUIPMENT MARKET, BY REGION,
2019–2026 (USD MILLION) 122
9.2 EUROPE 122
FIGURE 31 EUROPE: PATIENT HANDLING EQUIPMENT MARKET SNAPSHOT 123
TABLE 61 EUROPE: PATIENT HANDLING EQUIPMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 124
TABLE 62 EUROPE: PATIENT HANDLING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 124
TABLE 63 EUROPE: PATIENT TRANSFER DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 125
TABLE 64 EUROPE: PATIENT LIFTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 125
TABLE 65 EUROPE: AIR-ASSISTED LATERAL TRANSFER MATTRESSES MARKET, BY TYPE, 2019–2026 (USD MILLION) 125
TABLE 66 EUROPE: MEDICAL BEDS MARKET, BY TYPE, 2019–2026 (USD MILLION) 126
TABLE 67 EUROPE: MEDICAL BEDS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 126
TABLE 68 EUROPE: MOBILITY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 126
TABLE 69 EUROPE: WHEELCHAIRS & SCOOTERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 127
TABLE 70 EUROPE: PATIENT HANDLING EQUIPMENT MARKET, BY END USER,
2019–2026 (USD MILLION) 127
9.2.1 GERMANY 127
9.2.1.1 Germany dominates the European patient handling equipment market 127
TABLE 71 GERMANY: PATIENT HANDLING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 128
TABLE 72 GERMANY: PATIENT TRANSFER DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 128
TABLE 73 GERMANY: PATIENT LIFTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 129
TABLE 74 GERMANY: AIR-ASSISTED LATERAL TRANSFER MATTRESSES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 129
TABLE 75 GERMANY: MEDICAL BEDS MARKET, BY TYPE, 2019–2026 (USD MILLION) 129
TABLE 76 GERMANY: MEDICAL BEDS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 130
TABLE 77 GERMANY: MOBILITY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 130
TABLE 78 GERMANY: WHEELCHAIRS & SCOOTERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 130
TABLE 79 GERMANY: PATIENT HANDLING EQUIPMENT MARKET, BY END USER,
2019–2026 (USD MILLION) 131
9.2.2 UK 131
9.2.2.1 Wide acceptance of the no-lift approach has increased the adoption of patient handling equipment in the country 131
TABLE 80 UK: PATIENT HANDLING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 132
TABLE 81 UK: PATIENT TRANSFER DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 132
TABLE 82 UK: PATIENT LIFTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 132
TABLE 83 UK: AIR-ASSISTED LATERAL TRANSFER MATTRESSES MARKET, BY TYPE, 2019–2026 (USD MILLION) 133
TABLE 84 UK: MEDICAL BEDS MARKET, BY TYPE, 2019–2026 (USD MILLION) 133
TABLE 85 UK: MEDICAL BEDS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 133
TABLE 86 UK: MOBILITY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 134
TABLE 87 UK: WHEELCHAIRS & SCOOTERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 134
TABLE 88 UK: PATIENT HANDLING EQUIPMENT MARKET, BY END USER,
2019–2026 (USD MILLION) 134
9.2.3 FRANCE 134
9.2.3.1 Rising healthcare expenditure and favorable reimbursement scenario to support market growth in France 134
TABLE 89 FRANCE: PATIENT HANDLING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 135
TABLE 90 FRANCE: PATIENT TRANSFER DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 135
TABLE 91 FRANCE: PATIENT LIFTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 136
TABLE 92 FRANCE: AIR-ASSISTED LATERAL TRANSFER MATTRESSES MARKET, BY TYPE, 2019–2026 (USD MILLION) 136
TABLE 93 FRANCE: MEDICAL BEDS MARKET, BY TYPE, 2019–2026 (USD MILLION) 136
TABLE 94 FRANCE: MEDICAL BEDS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 137
TABLE 95 FRANCE: MOBILITY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 137
TABLE 96 FRANCE: WHEELCHAIRS & SCOOTERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 137
TABLE 97 FRANCE: PATIENT HANDLING EQUIPMENT MARKET, BY END USER,
2019–2026 (USD MILLION) 138
9.2.4 ITALY 138
9.2.4.1 Adoption of patient lifting techniques in the Italian healthcare industry will reduce the economic burden of fall injuries and MSDs 138
TABLE 98 ITALY: PATIENT HANDLING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 139
TABLE 99 ITALY: PATIENT TRANSFER DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 139
TABLE 100 ITALY: PATIENT LIFTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 139
TABLE 101 ITALY: AIR-ASSISTED LATERAL TRANSFER MATTRESSES MARKET, BY TYPE, 2019–2026 (USD MILLION) 140
TABLE 102 ITALY: MEDICAL BEDS MARKET, BY TYPE, 2019–2026 (USD MILLION) 140
TABLE 103 ITALY: MEDICAL BEDS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 140
TABLE 104 ITALY: MOBILITY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 141
TABLE 105 ITALY: WHEELCHAIRS & SCOOTERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 141
TABLE 106 ITALY: PATIENT HANDLING EQUIPMENT MARKET, BY END USER,
2019–2026 (USD MILLION) 141
9.2.5 SPAIN 142
9.2.5.1 Increasing life expectancy has driven the adoption of patient handling equipment in Spain 142
TABLE 107 SPAIN: PATIENT HANDLING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 142
TABLE 108 SPAIN: PATIENT TRANSFER DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 142
TABLE 109 SPAIN: PATIENT LIFTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 143
TABLE 110 SPAIN: AIR-ASSISTED LATERAL TRANSFER MATTRESSES MARKET, BY TYPE, 2019–2026 (USD MILLION) 143
TABLE 111 SPAIN: MEDICAL BEDS MARKET, BY TYPE, 2019–2026 (USD MILLION) 143
TABLE 112 SPAIN: MEDICAL BEDS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 144
TABLE 113 SPAIN: MOBILITY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 144
TABLE 114 SPAIN: WHEELCHAIRS & SCOOTERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 144
TABLE 115 SPAIN: PATIENT HANDLING EQUIPMENT MARKET, BY END USER,
2019–2026 (USD MILLION) 145
9.2.6 REST OF EUROPE 145
TABLE 116 ROE: PATIENT HANDLING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 145
TABLE 117 ROE: PATIENT TRANSFER DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 146
TABLE 118 ROE: PATIENT LIFTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 146
TABLE 119 ROE: AIR-ASSISTED LATERAL TRANSFER MATTRESSES MARKET, BY TYPE, 2019–2026 (USD MILLION) 146
TABLE 120 ROE: MEDICAL BEDS MARKET, BY TYPE, 2019–2026 (USD MILLION) 147
TABLE 121 ROE: MEDICAL BEDS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 147
TABLE 122 ROE: MOBILITY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 147
TABLE 123 ROE: WHEELCHAIRS & SCOOTERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 148
TABLE 124 ROE: PATIENT HANDLING EQUIPMENT MARKET, BY END USER,
2019–2026 (USD MILLION) 148
9.3 NORTH AMERICA 148
TABLE 125 NORTH AMERICA: PATIENT HANDLING EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 148
TABLE 126 NORTH AMERICA: PATIENT HANDLING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 149
TABLE 127 NORTH AMERICA: PATIENT TRANSFER DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 149
TABLE 128 NORTH AMERICA: PATIENT LIFTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 149
TABLE 129 NORTH AMERICA: AIR-ASSISTED LATERAL TRANSFER MATTRESSES MARKET, BY TYPE, 2019–2026 (USD MILLION) 150
TABLE 130 NORTH AMERICA: MEDICAL BEDS MARKET, BY TYPE,
2019–2026 (USD MILLION) 150
TABLE 131 NORTH AMERICA: MEDICAL BEDS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 150
TABLE 132 NORTH AMERICA: MOBILITY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 151
TABLE 133 NORTH AMERICA: WHEELCHAIRS & SCOOTERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 151
TABLE 134 NORTH AMERICA: PATIENT HANDLING EQUIPMENT MARKET, BY END USER, 2019–2026 (USD MILLION) 151
9.3.1 US 152
9.3.1.1 Increasing prevalence of obesity is driving market growth in the US 152
TABLE 135 US: PATIENT HANDLING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 152
TABLE 136 US: PATIENT TRANSFER DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 153
TABLE 137 US: PATIENT LIFTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 153
TABLE 138 US: AIR-ASSISTED LATERAL TRANSFER MATTRESSES MARKET, BY TYPE, 2019–2026 (USD MILLION) 153
TABLE 139 US: MEDICAL BEDS MARKET, BY TYPE, 2019–2026 (USD MILLION) 154
TABLE 140 US: MEDICAL BEDS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 154
TABLE 141 US: MOBILITY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 154
TABLE 142 US: WHEELCHAIRS & SCOOTERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 155
TABLE 143 US: PATIENT HANDLING EQUIPMENT MARKET, BY END USER,
2019–2026 (USD MILLION) 155
9.3.2 CANADA 155
9.3.2.1 Growth in the disabled population to boost the demand for patient handling equipment 155
TABLE 144 CANADA: PATIENT HANDLING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 156
TABLE 145 CANADA: PATIENT TRANSFER DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 156
TABLE 146 CANADA: PATIENT LIFTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 156
TABLE 147 CANADA: AIR-ASSISTED LATERAL TRANSFER MATTRESSES MARKET, BY TYPE, 2019–2026 (USD MILLION) 157
TABLE 148 CANADA: MEDICAL BEDS MARKET, BY TYPE, 2019–2026 (USD MILLION) 157
TABLE 149 CANADA: MEDICAL BEDS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 157
TABLE 150 CANADA: MOBILITY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 158
TABLE 151 CANADA: WHEELCHAIRS & SCOOTERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 158
TABLE 152 CANADA: PATIENT HANDLING EQUIPMENT MARKET, BY END USER,
2019–2026 (USD MILLION) 158
9.4 ASIA PACIFIC 159
FIGURE 32 ASIA PACIFIC: PATIENT HANDLING EQUIPMENT MARKET SNAPSHOT 159
TABLE 153 APAC: PATIENT HANDLING EQUIPMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 160
TABLE 154 APAC: PATIENT HANDLING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 160
TABLE 155 APAC: PATIENT TRANSFER DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 160
TABLE 156 APAC: PATIENT LIFTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 161
TABLE 157 APAC: AIR-ASSISTED LATERAL TRANSFER MATTRESSES MARKET, BY TYPE, 2019–2026 (USD MILLION) 161
TABLE 158 APAC: MEDICAL BEDS MARKET, BY TYPE, 2019–2026 (USD MILLION) 161
TABLE 159 APAC: MEDICAL BEDS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 162
TABLE 160 APAC: MOBILITY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 162
TABLE 161 APAC: WHEELCHAIRS & SCOOTERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 162
TABLE 162 APAC: PATIENT HANDLING EQUIPMENT MARKET, BY END USER,
2019–2026 (USD MILLION) 163
9.4.1 JAPAN 163
9.4.1.1 Japan accounts for the largest share of the APAC patient handling equipment market 163
TABLE 163 JAPAN: PATIENT HANDLING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 164
TABLE 164 JAPAN: PATIENT TRANSFER DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 164
TABLE 165 JAPAN: PATIENT LIFTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 164
TABLE 166 JAPAN: AIR-ASSISTED LATERAL TRANSFER MATTRESSES MARKET, BY TYPE, 2019–2026 (USD MILLION) 165
TABLE 167 JAPAN: MEDICAL BEDS MARKET, BY TYPE, 2019–2026 (USD MILLION) 165
TABLE 168 JAPAN: MEDICAL BEDS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 165
TABLE 169 JAPAN: MOBILITY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 166
TABLE 170 JAPAN: WHEELCHAIRS & SCOOTERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 166
TABLE 171 JAPAN: PATIENT HANDLING EQUIPMENT MARKET, BY END USER,
2019–2026 (USD MILLION) 166
9.4.2 CHINA 167
9.4.2.1 Growing number of hospitals to propel market growth 167
TABLE 172 CHINA: PATIENT HANDLING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 167
TABLE 173 CHINA: PATIENT TRANSFER DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 168
TABLE 174 CHINA: PATIENT LIFTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 168
TABLE 175 CHINA: AIR-ASSISTED LATERAL TRANSFER MATTRESSES MARKET, BY TYPE, 2019–2026 (USD MILLION) 168
TABLE 176 CHINA: MEDICAL BEDS MARKET, BY TYPE, 2019–2026 (USD MILLION) 169
TABLE 177 CHINA: MEDICAL BEDS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 169
TABLE 178 CHINA: MOBILITY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 169
TABLE 179 CHINA: WHEELCHAIRS & SCOOTERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 170
TABLE 180 CHINA: PATIENT HANDLING EQUIPMENT MARKET, BY END USER,
2019–2026 (USD MILLION) 170
9.4.3 INDIA 170
9.4.3.1 Adoption of safety guidelines for patient handling in hospitals to drive the demand for patient handling equipment 170
TABLE 181 INDIA: PATIENT HANDLING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 171
TABLE 182 INDIA: PATIENT TRANSFER DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 171
TABLE 183 INDIA: PATIENT LIFTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 171
TABLE 184 INDIA: AIR-ASSISTED LATERAL TRANSFER MATTRESSES MARKET, BY TYPE, 2019–2026 (USD MILLION) 172
TABLE 185 INDIA: MEDICAL BEDS MARKET, BY TYPE, 2019–2026 (USD MILLION) 172
TABLE 186 INDIA: MEDICAL BEDS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 172
TABLE 187 INDIA: MOBILITY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 173
TABLE 188 INDIA: WHEELCHAIRS & SCOOTERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 173
TABLE 189 INDIA: PATIENT HANDLING EQUIPMENT MARKET, BY END USER,
2019–2026 (USD MILLION) 173
9.4.4 REST OF ASIA PACIFIC 173
TABLE 190 ROAPAC: PATIENT HANDLING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 174
TABLE 191 ROAPAC: PATIENT TRANSFER DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 174
TABLE 192 ROAPAC: PATIENT LIFTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 175
TABLE 193 ROAPAC: AIR-ASSISTED LATERAL TRANSFER MATTRESSES MARKET, BY TYPE, 2019–2026 (USD MILLION) 175
TABLE 194 ROAPAC: MEDICAL BEDS MARKET, BY TYPE, 2019–2026 (USD MILLION) 175
TABLE 195 ROAPAC: MEDICAL BEDS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 176
TABLE 196 ROAPAC: MOBILITY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 176
TABLE 197 ROAPAC: WHEELCHAIRS & SCOOTERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 176
TABLE 198 ROAPAC: PATIENT HANDLING EQUIPMENT MARKET, BY END USER,
2019–2026 (USD MILLION) 177
9.5 LATIN AMERICA 177
TABLE 199 LATIN AMERICA: PATIENT HANDLING EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 177
TABLE 200 LATIN AMERICA: PATIENT HANDLING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 178
TABLE 201 LATIN AMERICA: PATIENT TRANSFER DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 178
TABLE 202 LATIN AMERICA: PATIENT LIFTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 178
TABLE 203 LATIN AMERICA: AIR-ASSISTED LATERAL TRANSFER MATTRESSES MARKET, BY TYPE, 2019–2026 (USD MILLION) 179
TABLE 204 LATIN AMERICA: MEDICAL BEDS MARKET, BY TYPE,
2019–2026 (USD MILLION) 179
TABLE 205 LATIN AMERICA: MEDICAL BEDS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 179
TABLE 206 LATIN AMERICA: MOBILITY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 180
TABLE 207 LATIN AMERICA: WHEELCHAIRS & SCOOTERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 180
TABLE 208 LATIN AMERICA: PATIENT HANDLING EQUIPMENT MARKET, BY END USER, 2019–2026 (USD MILLION) 180
9.5.1 BRAZIL 181
9.5.1.1 Brazil is the largest market for patient handling equipment in Latin America 181
TABLE 209 BRAZIL: PATIENT HANDLING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 181
TABLE 210 BRAZIL: PATIENT TRANSFER DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 181
TABLE 211 BRAZIL: PATIENT LIFTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 182
TABLE 212 BRAZIL: AIR-ASSISTED LATERAL TRANSFER MATTRESSES MARKET, BY TYPE, 2019–2026 (USD MILLION) 182
TABLE 213 BRAZIL: MEDICAL BEDS MARKET, BY TYPE, 2019–2026 (USD MILLION) 182
TABLE 214 BRAZIL: MEDICAL BEDS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 183
TABLE 215 BRAZIL: MOBILITY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 183
TABLE 216 BRAZIL: WHEELCHAIRS & SCOOTERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 183
TABLE 217 BRAZIL: PATIENT HANDLING EQUIPMENT MARKET, BY END USER,
2019–2026 (USD MILLION) 184
9.5.2 MEXICO 184
9.5.2.1 Mexico to register the highest growth in the Latin American patient handling equipment market 184
TABLE 218 MEXICO: PATIENT HANDLING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 184
TABLE 219 MEXICO: PATIENT TRANSFER DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 185
TABLE 220 MEXICO: PATIENT LIFTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 185
TABLE 221 MEXICO: AIR-ASSISTED LATERAL TRANSFER MATTRESSES MARKET, BY TYPE, 2019–2026 (USD MILLION) 185
TABLE 222 MEXICO: MEDICAL BEDS MARKET, BY TYPE, 2019–2026 (USD MILLION) 186
TABLE 223 MEXICO: MEDICAL BEDS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 186
TABLE 224 MEXICO: MOBILITY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 186
TABLE 225 MEXICO: WHEELCHAIRS & SCOOTERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 187
TABLE 226 MEXICO: PATIENT HANDLING EQUIPMENT MARKET, BY END USER,
2019–2026 (USD MILLION) 187
9.5.3 REST OF LATIN AMERICA 187
TABLE 227 ROLA: PATIENT HANDLING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 188
TABLE 228 ROLA: PATIENT TRANSFER DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 188
TABLE 229 ROLA: PATIENT LIFTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 188
TABLE 230 ROLA: AIR-ASSISTED LATERAL TRANSFER MATTRESSES MARKET, BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 231 ROLA: MEDICAL BEDS MARKET, BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 232 ROLA: MEDICAL BEDS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 189
TABLE 233 ROLA: MOBILITY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 190
TABLE 234 ROLA: WHEELCHAIRS & SCOOTERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 190
TABLE 235 ROLA: PATIENT HANDLING EQUIPMENT MARKET, BY END USER,
2019–2026 (USD MILLION) 190
9.6 MIDDLE EAST & AFRICA 190
TABLE 236 MIDDLE EAST & AFRICA: PATIENT HANDLING EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 191
TABLE 237 MIDDLE EAST & AFRICA: PATIENT TRANSFER DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 191
TABLE 238 MIDDLE EAST & AFRICA: PATIENT LIFTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 192
TABLE 239 MIDDLE EAST & AFRICA: AIR-ASSISTED LATERAL TRANSFER MATTRESSES MARKET, BY TYPE, 2019–2026 (USD MILLION) 192
TABLE 240 MIDDLE EAST & AFRICA: MEDICAL BEDS MARKET, BY TYPE,
2019–2026 (USD MILLION) 192
TABLE 241 MIDDLE EAST & AFRICA: MEDICAL BEDS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 193
TABLE 242 MIDDLE EAST & AFRICA: MOBILITY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 193
TABLE 243 MIDDLE EAST & AFRICA: WHEELCHAIRS & SCOOTERS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 193
TABLE 244 MIDDLE EAST & AFRICA: PATIENT HANDLING EQUIPMENT MARKET,
BY END USER, 2019–2026 (USD MILLION) 194
10 COMPETITIVE LANDSCAPE 195
10.1 OVERVIEW 195
FIGURE 33 KEY PLAYER STRATEGIES 195
10.2 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 196
FIGURE 34 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE PATIENT
HANDLING EQUIPMENT MARKET 196
10.3 MARKET SHARE ANALYSIS 196
FIGURE 35 PATIENT HANDLING EQUIPMENT MARKET SHARE ANALYSIS,
BY KEY PLAYER, 2020 197
10.4 COMPETITIVE LEADERSHIP MAPPING 198
10.4.1 STARS 198
10.4.2 EMERGING LEADERS 198
10.4.3 PERVASIVE PLAYERS 198
10.4.4 PARTICIPANTS 198
FIGURE 36 PATIENT HANDLING EQUIPMENT MARKET: COMPETITIVE LEADERSHIP MAPPING (2020) 199
 
10.5 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS 199
10.5.1 PROGRESSIVE COMPANIES 199
10.5.2 DYNAMIC COMPANIES 200
10.5.3 STARTING BLOCKS 200
10.5.4 RESPONSIVE COMPANIES 200
FIGURE 37 PATIENT HANDLING EQUIPMENT MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2020) 200
10.6 COMPETITIVE SCENARIO 201
10.6.1 PRODUCT LAUNCHES 201
TABLE 245 PRODUCT LAUNCHES, JANUARY 2018–OCTOBER 2021 201
10.6.2 DEALS 201
TABLE 246 DEALS, JANUARY 2018–OCTOBER 2021 201
10.7 COMPETITIVE BENCHMARKING 202
FIGURE 38 FOOTPRINT OF COMPANIES IN THE PATIENT HANDLING EQUIPMENT MARKET 202
TABLE 247 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES) 203
TABLE 248 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES) 204

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127